BioNTech SE (BNTX) Operating Leases (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Operating Leases data on file, last reported at $242.0 million in Q3 2025.

• In Q3 2025, Operating Leases changed N/A year-over-year to $242.0 million; the TTM figure through Sep 2025 stood at $242.0 million (changed N/A YoY), while the FY2024 annual figure was $271.6 million, up 16.5% from the prior year.
• Operating Leases declined to $242.0 million in Q3 2025, from $260.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $274.4 million in Q3 2022 and bottomed at $117.7 million in Q2 2021.
• A 5-year average of $225.4 million and a median of $242.0 million in 2025 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2022 — Operating Leases surged 115.3% — and 2025, when it gained 2.12%.
• Year by year, Operating Leases stood at $207.7 million in 2021, then advanced by 3.18% to $214.4 million in 2022, then gained by 8.77% to $233.2 million in 2023, then gained by 16.5% to $271.6 million in 2024, then declined by 10.91% to $242.0 million in 2025.
• The last three Operating Leases figures came in at $242.0 million (Q3 2025), $260.5 million (Q2 2025), and $259.6 million (Q1 2025), per Business Quant data.

Peer Comparison